Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10555937 Pharmaceutical compositions

Patent 10555937 was granted and assigned to Xspray Microparticles AB on February, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
‌
Xspray Microparticles AB
0
Date Filed
May 6, 2019
0
Date of Patent
February 11, 2020
0
Patent Applicant
‌
Xspray Microparticles AB
0
Patent Application Number
16404027
0
Patent Citations
‌
US Patent 10143683 Pharmaceutical compositions
0
Patent Citations Received
‌
US Patent 11633398 Amorphous solid dispersions of dasatinib and uses thereof
0
‌
US Patent 11298356 Amorphous solid dispersions of dasatinib and uses thereof
‌
US Patent 11324745 Amorphous solid dispersions of dasatinib and uses thereof
0
‌
US Patent 11389450 Amorphous nilotinib microparticles and uses thereof
‌
US Patent 11413290 Amorphous solid dispersions of dasatinib and uses thereof
‌
US Patent 11980619 Pharmaceutical compositions and crushable tablets including amorphous solid dispersions of dasatinib and uses
0
‌
US Patent 11998548 Amorphous nilotinib microparticles and uses thereof
0
‌
US Patent 12016861 Amorphous nilotinib microparticles and uses thereof
0
‌
US Patent 11559485 Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib
Patent Inventor Names
Helene Dérand
0
Martin Malmsten
0
Mustafa Demirbüker
0
Gérald Jesson
0
Magnus Brisander
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10555937
0
Patent Primary Examiner
‌
Jeffrey T. Palenik
0

Find more entities like US Patent 10555937 Pharmaceutical compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo